US SB1132 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on April 15 2021 - 25% progression
Action: 2021-04-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin. Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement. This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals. The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

EPI Act Ending Pricey Insulin Act

Sponsors


History

DateChamberAction
2021-04-15SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback